Lincoln Public Schools

Lincoln Public Schools Takes Action

Related Correspondance

• Letter sent to LPS families
• Letter sent to LPS staff

Resources on the Web

• Lincoln Lancaster County Health Department Web site
• Flu.gov: CDC influenza site with multiple links and information
• This contains information specific to schools

Action Steps for Parents

• If School is Dismissed or Children are Sick and Must Stay Home
• For Parents to Protect Their Child and Family from the Flu this School Year
• For Parents of Children at High Risk for Flu Complications

Action Steps for Teachers

• For Teachers to Prevent the Spread of Flu

Flu.gov News Releases

• Weekly FluView Map and Surveillance Report for Week ending November 14, 2009
  Weekly FluView Map and Surveillance Report for Week ending November 14, 2009
• Public Health Significance of Virus Mutation detected in Norway
  The Norwegian Institute of Public Health has informed WHO of a mutation detected in three H1N1 viruses. The viruses were isolated from the first two fatal cases of pandemic influenza in the country and one patient with severe illness.
• WHO Updates International H1N1 Flu Situation
  As of 15 November 2009, worldwide more than 206 countries and overseas territories or communities have reported laboratory confirmed cases of pandemic influenza H1N1 2009, including over 6770 deaths.
• Updated Guidance for the Use of CSL 2009 H1N1 Monovalent Vaccine
  Updated Guidance for the Use of CSL 2009 H1N1 Monovalent Vaccine
• WHO: Safety of Pandemic Vaccines
  To date, WHO has received vaccination information from 16 of around 40 countries conducting national H1N1 pandemic vaccine campaigns.
• Questions and Answers: 2009 H1N1 and Pneumococcal Disease in the News
  Invasive pneumococcal disease is an infection caused by a type of bacteria called Streptococcus pneumoniae (pneumococcus).
• FTC Warns Internet Peddlers that Marketing Unproven H1N1 Flu Products May Be Illegal
  The Federal Trade Commission last week sent 10 warning letters to Web site operators who made questionable claims that their products can prevent, treat, or cure the H1N1 flu, commonly known as swine flu.
• 2009 H1N1 Flu
  Situation Update. During the week of November 1-7, 2009, influenza activity remained high in the United States, with some key indicators decreasing slightly and others continuing to climb.
• Immune System of Healthy Adults May Be Better Prepared Than Expected to Fight 2009 H1N1 Influenza Virus
  A new study shows that molecular similarities exist between the 2009 H1N1 influenza virus and other strains of seasonal H1N1 virus that have been circulating in the population since 1988.
• FDA Approves Additional Vaccine for 2009 H1N1 Influenza Virus
  The U.S. Food and Drug Administration announced that it has approved a fifth vaccine for protection against the 2009 H1N1 influenza virus.
• WHO Updates International H1N1 Flu Situation
  As of 8 November 2009, worldwide more than 206 countries and overseas territories or communities have reported laboratory confirmed cases of pandemic influenza H1N1 2009, including over 6250 deaths.
• WHO: Interim Planning Considerations for Mass Gatherings in the Context of Pandemic (H1N1) 2009 Influenza (PDF - 163 KB)
  Mass gatherings are highly visible events with the potential for serious public health and political consequences if they are not planned and managed carefully.
• Information for Pregnant Women Working in Education, Child Care, and Health Care Settings Concerning 2009 H1N1 Influenza Virus
  All 2009 H1N1 guidance is interim and subject to review and revision as more is learned about this novel influenza virus. This guidance may be revised in the event that the 2009 H1N1 pandemic increases in severity compared with the situation in spring/summer 2009.
• Disabilities and the Flu
  Having a disability alone may not place someone at higher risk for complications from the H1N1 virus, but other factors may put a person with disabilities at higher risk.
• FDA Expands Approved Use of H1N1 Vaccines to Include Infants and Children
  The U.S. Food and Drug Administration has approved the use of the CSL Limited’s 2009 H1N1 influenza vaccine to include children ages 6 months and older. This vaccine was previously approved only for use in adults, ages 18 years and older. “Because children are among those most vulnerable to the 2009 H1N1 virus, having a broader range of children’s vaccines available is an important step in responding to the H1N1 outbreak,” said Margaret A. Hamburg, M.D., commissioner of food and drugs.
• Interim Guidance: Considerations Regarding 2009 H1N1 Influenza in Intrapartum and Postpartum Hospital Settings
  This interim guidance has been updated to replace previously posted guidance entitled "Considerations Regarding Novel H1N1 Flu Virus in Obstetric Settings", dated July 6, 2009. This document clarifies clinical considerations related to management of suspected or confirmed maternal infection with 2009 H1N1 influenza virus infection within labor and delivery, postpartum, and newborn care settings in hospitals. A cautious approach to the management of ill mothers and their newborns is still recommended, but several options are provided based on hospital configuration, staffing, and surge capacity.
• FDA Commissioner Addresses Nation’s Doctors on H1N1 Vaccine
  FDA Commissioner thanks doctors for their efforts and provides information on the safety of H1N1 vaccines.
• Weekly FluView Map and Surveillance Report for Week ending October 31, 2009
  All data are preliminary and may change as more reports are received.
• Key Issues for Clinicians Concerning Antiviral Treatments for 2009 H1N1: Health Alert Network (HAN) Message
  Although use of influenza antiviral drugs in the United States has increased during the 2009-2010 flu season, not all people recommended for antiviral treatment are getting treated.